AngioDynamics, The PERT Consortium™ and Viz.ai partner on APEX Study to facilitate future enrollment to bring innovative treatment to patients with PE.
Learn More
AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.
These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes.
The AlphaVac system is an off the shelf, easy to assemble, emergent mechanical aspiration device, allowing for efficient procedure time…
Today, localized therapy options are limited in providing physicians and patients with a customizable and confident treatment. Most options come…
Engineered with your practice and your patients in mind, The Auryon System is designed with industry-leading technology and features that…
It takes a team of talented people to become one of the world’s leading providers of innovative medical devices.
The deep commitment and contributions of our employees helped to build a global company that’s pioneering new ways to improve patient outcomes.
If you find the idea of joining a dynamic team that’s dedicated to improving the lives of patients appealing, we invite you to review our available opportunities.
Our Future of Focal Therapy Master Course is making major waves with physicians and clinical leaders in the fields of urology, interventional radiology, and radiologic oncology. We are excited to host another round in Tampa, FL this weekend with over 25 physicians in attendance!
We look forward to seeing you in less than two weeks, January 29 - 30, in San Diego at #STS. Visit booth 1416 to learn more about #AngioVac and innovative restorative flow therapy options.
Risk Info: https://lnkd.in/eMY5_pN2
Spectrum '23 has come to a close! Thank you for joining us and learning about the #NanoKnife System & #IRE technology through educational sessions, impactful presentations, & meaningful discussions. We are grateful for your efforts to expand treatment options worldwide.
Congratulations to @aghiliNima and Patrick Rudersdorf, MD of St. Anthony’s in Colorado on completing their first AngioVac F1885 case. Thank you for leading the way in utilizing innovative technology to further the care you give your patients. Risk info: https://lnkd.in/gFNG_pA
AngioDynamics® history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach.
Latham, NY (HQ)
Glens Falls, NY (Manufacturing)
Queensbury, NY (Manufacturing)
Marlborough, MA (R&D)
Amsterdam, NL (International HQ)
São Paulo, BR (Brazil Office)
Oakville, CA (Canada Office)
Hong Kong, HK (Asia Pacific Regional Office)
Rehovot, IL (Israel Office)
